An antagonist of mGluR1 and mGluR2
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

E4CPG

Item No. 36667

Technical Information
Formal Name
α-amino-4-carboxy-α-ethyl-benzeneacetic acid
CAS Number
170846-89-6
Synonyms
  • (R,S)-α-Ethyl-4-carboxyphenylglycine
Molecular Formula
C11H13NO4
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: insolDMSO: insolEthanol: insolPBS (pH 7.2): 100 µg/ml
λmax
233 nm
SMILES
O=C(C1=CC=C(C(C(O)=O)(CC)N)C=C1)O
InChi Code
InChI=1S/C11H13NO4/c1-2-11(12,10(15)16)8-5-3-7(4-6-8)9(13)14/h3-6H,2,12H2,1H3,(H,13,14)(H,15,16)
InChi Key
AIEFWRHRHFRLFT-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    E4CPG is an antagonist of metabotropic glutamate receptor 1 (mGluR1) and mGluR2.1 It is selective for mGluR1 and mGluR2 over mGluR6 at 1 mM. E4CPG (1 mM) inhibits L-glutamate-induced increases in inositol phosphate (InsP) levels in CHO cells expressing mGluR1 and prevents forskolin-induced decreases in cAMP levels in CHO cells expressing mGluR2. In vivo, intraplantar administration of E4CPG (1-10 nmol/paw) reduces glutamate-induced paw licking in a mouse model of nociceptive pain.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sekiyama, N., Hayashi, Y., Nakanishi, S., et alStructure-activity relationships of new agonists and antagonists of different metabotropic glutamate receptor subtypes. Br. J. Pharmacol. 117(7), 1493-1503 (1996).

    2. Beirith, A., Santos, A.R.S., and Calixto, J.B. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Res. 924(2), 219-228 (2002).